Chromadex Corp
NASDAQ:CDXC
Chromadex Corp
Accounts Receivables
Chromadex Corp
Accounts Receivables Peer Comparison
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Chromadex Corp
NASDAQ:CDXC
|
Accounts Receivables
$3.9m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
9%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Accounts Receivables
$9.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
|
Danaher Corp
NYSE:DHR
|
Accounts Receivables
$3.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Accounts Receivables
$650.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
Agilent Technologies Inc
NYSE:A
|
Accounts Receivables
$1.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Accounts Receivables
$3.4B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
See Also
What is Chromadex Corp's Accounts Receivables?
Accounts Receivables
3.9m
USD
Based on the financial report for Mar 31, 2024, Chromadex Corp's Accounts Receivables amounts to 3.9m USD.
What is Chromadex Corp's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
9%
Over the last year, the Accounts Receivables growth was -69%. The average annual Accounts Receivables growth rates for Chromadex Corp have been 5% over the past three years , -2% over the past five years , and 9% over the past ten years .